ACTUATED MEDICAL, INC. — Department of Defense SBIR Phase II: CBD181-001

ACTUATED MEDICAL, INC. — SBIR Phase II award from Department of Defense.

Phase II SBIR prototype / development signal

  • Phase II is where Department of Defense funds deeper R&D after feasibility. Incumbents with Phase II history are serious competitors on adjacent topics.
  • Use this award as past-performance context and to map customer organizations for STRATFI/TACFI-style transition planning.
  • Obligated amount $527,555 is consistent with substantial Phase II-scale effort; compare to related awards from the same agency.
  • Topic code CBD181-001 links this award to a solicitation family — search the same topic stem for incumbents and recompete timing.

Informational capture context from public federal data — not legal or bid advice.

Amount
$527,555
Agency
Department of Defense · Office for Chemical and Biological Defense
Program / Phase
SBIR · Phase II
Topic
CBD181-001
Solicitation
18.1
NAICS
Place of performance
PA
Period
2020-05-05 → 2021-05-07

Description

Department of Defense personnel must wear respiratory protection continuously when deployed in regions with the danger of chemical or biological attack. Manufacturing respirators/masks using conventional molding methods limits the features that can be designed into the protection. Additive manufacturing provides an ideal approach for manufacturing respirators. Additive Manufacturing enables the ability for 1) New features that cannot be achieved with molding processes, including better and more comfortable fit, 2) Modification to mask design without having to invest the time and funds in new molds, 3) Masks that are custom-fit to the facial structure of the end-user, and 4) the Ability to print multifunctional composite materials. Phase I demonstrated 3D printed flexible resins that exhibited compelling permeation resistance against chemical warfare agent simulants. In this Phase II SBIR, Actuated Medical, Inc. (AMI), an ISO 13485-Certified (FDA GMP Compliant) Medical Device Developer and Manufacturer, will finalize and commercialize 3D Printing of Flexible Polymers for Respiratory Protection. The flexible polymers will find additional use in 3D printing of medical devices and masks for first-responders.